Zhang W - Search Results

1

Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation.

Zhang W, Zhou L, Ding SM, Xie HY, Xu X, Wu J, Chen QX, Zhang F, Wei BJ, Eldin AT, Zheng SS. Zhang W, et al. Among authors: zhang f. Oncol Rep. 2011 Apr;25(4):1053-62. doi: 10.3892/or.2011.1159. Epub 2011 Jan 24. Oncol Rep. 2011. PMID: 21271221

2

Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients.

Jiang Z, Feng X, Zhang W, Gao F, Ling Q, Zhou L, Xie H, Chen Q, Zheng S. Jiang Z, et al. Among authors: zhang w. Liver Int. 2007 Nov;27(9):1202-8. doi: 10.1111/j.1478-3231.2007.01553.x. Liver Int. 2007. PMID: 17919231

3

Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells through mitochondria-operated pathway.

Zhang W, Wu J, Zhou L, Xie HY, Zheng SS. Zhang W, et al. Indian J Exp Biol. 2010 Dec;48(12):1167-74. Indian J Exp Biol. 2010. PMID: 21250597

4

Tri-iodothyronine enhances liver regeneration after living donor liver transplantation in rats.

Taki-Eldin A, Zhou L, Xie HY, Chen KJ, Zhou WH, Zhang W, Xing CY, Yang Z, Zhang K, Zheng SS. Taki-Eldin A, et al. Among authors: zhang w, zhang k. J Hepatobiliary Pancreat Sci. 2011 Nov;18(6):806-14. doi: 10.1007/s00534-011-0397-2. J Hepatobiliary Pancreat Sci. 2011. PMID: 21584707

5

Methylation profile of single hepatocytes derived from hepatitis B virus-related hepatocellular carcinoma.

Tao R, Li J, Xin J, Wu J, Guo J, Zhang L, Jiang L, Zhang W, Yang Z, Li L. Tao R, et al. Among authors: zhang l, zhang w. PLoS One. 2011;6(5):e19862. doi: 10.1371/journal.pone.0019862. Epub 2011 May 23. PLoS One. 2011. PMID: 21625442 Free PMC article.

6

NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.

Cheng J, Xie HY, Xu X, Wu J, Wei X, Su R, Zhang W, Lv Z, Zheng S, Zhou L. Cheng J, et al. Among authors: zhang w. Cancer Lett. 2011 Nov 1;310(1):35-45. doi: 10.1016/j.canlet.2011.06.001. Epub 2011 Jun 24. Cancer Lett. 2011. PMID: 21763068

7

Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation.

Xing C, Xie H, Zhou L, Zhou W, Zhang W, Ding S, Wei B, Yu X, Su R, Zheng S. Xing C, et al. Among authors: zhang w. Biochem Biophys Res Commun. 2012 Mar 30;420(1):29-35. doi: 10.1016/j.bbrc.2012.02.107. Epub 2012 Feb 27. Biochem Biophys Res Commun. 2012. PMID: 22390936

8

FOXC1 contributes to microvascular invasion in primary hepatocellular carcinoma via regulating epithelial-mesenchymal transition.

Xu ZY, Ding SM, Zhou L, Xie HY, Chen KJ, Zhang W, Xing CY, Guo HJ, Zheng SS. Xu ZY, et al. Among authors: zhang w. Int J Biol Sci. 2012;8(8):1130-41. doi: 10.7150/ijbs.4769. Epub 2012 Sep 8. Int J Biol Sci. 2012. PMID: 22991501 Free PMC article.

9

Liver transplantation in Crigler-Najjar syndrome type I disease.

Tu ZH, Shang DS, Jiang JC, Zhang W, Zhang M, Wang WL, Lou HY, Zheng SS. Tu ZH, et al. Among authors: zhang m, zhang w. Hepatobiliary Pancreat Dis Int. 2012 Oct;11(5):545-8. doi: 10.1016/s1499-3872(12)60222-7. Hepatobiliary Pancreat Dis Int. 2012. PMID: 23060403

10

Reversing effect of ring finger protein 43 inhibition on malignant phenotypes of human hepatocellular carcinoma.

Xing C, Zhou W, Ding S, Xie H, Zhang W, Yang Z, Wei B, Chen K, Su R, Cheng J, Zheng S, Zhou L. Xing C, et al. Among authors: zhang w. Mol Cancer Ther. 2013 Jan;12(1):94-103. doi: 10.1158/1535-7163.MCT-12-0672. Epub 2012 Nov 6. Mol Cancer Ther. 2013. PMID: 23136185

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88,542 results

Search Page

Filters